Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination

This is a open-label, fixed-sequence, 3-period study being conducted in a single center to evaluate the following: * PK of CVC administered with and without PGZ * PK of PGZ administered with and without CVC * Safety of CVC administered with and without PGZ * Tolerability of CVC administered with and without PGZ